Sponsor

Zambon SpA

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Zambon SpA appears in 11 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials11
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

11 shown
Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic SubjectsNCT04229303 · lead sponsor · 2020-02-11
COMPLETED
An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PDNCT03994328 · lead sponsor · 2019-12-03
COMPLETED
Safinamide for Levodopa-induced Dyskinesia (PD-LID)NCT03987750 · lead sponsor · 2019-10-01
WITHDRAWN
A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of LevodopaNCT03881371 · lead sponsor · 2019-08-01
COMPLETED
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus SecretionsNCT03843541 · lead sponsor · 2019-06-25
COMPLETED
Effect of Safinamide on Parkinson's Disease Related Chronic PainNCT03841604 · lead sponsor · 2019-04-09
COMPLETED
Clinical Study to Evaluate Z7200 Pharmacokinetics ProfileNCT02631941 · lead sponsor · 2016-01-01
COMPLETED
A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy VolunteersNCT02237508 · lead sponsor · 2014-09-01
COMPLETED
Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic PatientsNCT02227394 · lead sponsor · 2014-08-01
COMPLETED
Cost-effectiveness of Nursing Interventions for Patients With PDNCT03830190 · collaborator · 2019-01-07
COMPLETED
COPD on Primary Care Treatment (COOPT)NCT00184977 · collaborator · 1998-12-01
COMPLETED

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Zambon SpA as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
acetylcysteine1
fluticasone propionate1
safinamide1
safinamide mesylate1
acetylcysteine RxCUI 197 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial fluticasone propionate RxCUI 50121 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial safinamide RxCUI 1922448 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial safinamide mesylate RxCUI 1922449 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor9
collaborator2
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.